120 related articles for article (PubMed ID: 32473819)
1. Analysis of recurrence trends according to risk groups after renal cancer nephrectomy.
Polanco Pujol L; Herranz Amo F; Caño Velasco J; Moralejo Gárate M; Subirá Ríos D; Barbas Bernardos G; Mayor de Castro J; Aragón Chamizo J; Husilllos Alonso A; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2020 Oct; 44(8):554-560. PubMed ID: 32473819
[TBL] [Abstract][Full Text] [Related]
2. Recurrence risk groups after nephrectomy for renal cell carcinoma.
Polanco Pujol L; Herranz Amo F; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Hernández Cavieres J; Barbas Bernardos G; Bueno Chomón G; Rodríguez Fernández E; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):111-118. PubMed ID: 31836313
[TBL] [Abstract][Full Text] [Related]
3. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
[TBL] [Abstract][Full Text] [Related]
4. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
5. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
6. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
[TBL] [Abstract][Full Text] [Related]
8. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
10. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
[TBL] [Abstract][Full Text] [Related]
11. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
[TBL] [Abstract][Full Text] [Related]
12. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
13. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
[TBL] [Abstract][Full Text] [Related]
14. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study.
Kang HW; Lee SK; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
J Surg Oncol; 2016 Jul; 114(1):70-4. PubMed ID: 27074886
[TBL] [Abstract][Full Text] [Related]
15. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
16. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
17. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
18. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy].
Huang JW; Cai W; Kong W; Zhang J; Chen YH; Huang YR
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):703-707. PubMed ID: 31550862
[No Abstract] [Full Text] [Related]
19. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
Ljungberg B; Alamdari FI; Rasmuson T; Roos G
BJU Int; 1999 Sep; 84(4):405-11. PubMed ID: 10468753
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.
Fukushima H; Masuda H; Yokoyama M; Tatokoro M; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
Jpn J Clin Oncol; 2013 Jul; 43(7):740-6. PubMed ID: 23729495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
